120 web-programmer-developer-"LIST" "https:" "https:" "https:" "https:" "https:" positions at City of Hope
Sort by
Refine Your Search
-
and validate experimental plan, methods, and results for accuracy and completeness. Develop new laboratory methods and help refine existing methodologies. Your qualifications should include
-
Pal, please visit here . For a complete list of Dr. Pal’s publications please visit here . As a successful candidate you will: · Develop and maintain clinical and translational research trials
-
(PMID: 30451821 ), Science Advances (DOI: 10.1126/sciadv.ado4274 ), and Cell Reports (DOI: DOI: 10.1016/j.celrep.2024.114951 ). For a complete list of publications, please visit Dr. Sun’s NCBI
-
successful candidate, you will: Reviews reports from Pathology, Cytology, Radiation Oncology and Nuclear Medicine patient treatment lists and New Patient Registration. Identifies each new case with a malignant
-
within the translational hematopathology program led by Dr. M. James You. The successful candidate will develop a focused research program aligned with the laboratory's core themes, including leukemic stem
-
custom functions on eCRFs to improve data quality. Develop specifications for standard edit checks, data listings and reports as needed. Work closely with research software developers / programmers
-
that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and
-
that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and
-
medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on epigenetics, RNA and chromatin biology and endothelial stress response. Her team integrates
-
of adipose tissue and its link to age-related metabolic disorders and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique